{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:25:20Z","timestamp":1792783520487,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014942","name":"Novartis Gene Therapies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014942","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scholar Rock","id":[{"id":"https:\/\/ror.org\/01036m381","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Biohaven Pharmaceuticals","id":[{"id":"https:\/\/ror.org\/00m2ky193","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Epirium Bio"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s40120-026-01012-z","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:29:12Z","timestamp":1787048952000},"page":"2551-2566","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Transition Plan Implementation and Provider Engagement Among Adults Living with Spinal Muscular Atrophy (SMA): Findings from a Cross-Sectional Survey"],"prefix":"10.1007","volume":"15","author":[{"given":"Lauren E.","family":"Eisenman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie R.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0747-4669","authenticated-orcid":false,"given":"Mary A.","family":"Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"1012_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155\u201365. https:\/\/doi.org\/10.1016\/0092-8674(95)90460-3.","journal-title":"Cell"},{"key":"1012_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28:103\u201315. https:\/\/doi.org\/10.1016\/j.nmd.2017.11.005.","journal-title":"Neuromuscul Disord"},{"key":"1012_CR3","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1001\/jamapediatrics.2024.1911","volume":"178","author":"L Belter","year":"2024","unstructured":"Belter L, Taylor JL, Jorgensen E, Glascock J, Whitmire SM, Tingey JJ, et al. Newborn screening and birth prevalence for spinal muscular atrophy in the US. JAMA Pediatr. 2024;178:946. https:\/\/doi.org\/10.1001\/jamapediatrics.2024.1911.","journal-title":"JAMA Pediatr"},{"key":"1012_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s1474-4422(23)00419-2","volume":"23","author":"CJJ Yeo","year":"2024","unstructured":"Yeo CJJ, Tizzano EF, Darras BT. Challenges and opportunities in spinal muscular atrophy therapeutics. Lancet Neurol. 2024;23:205\u201318. https:\/\/doi.org\/10.1016\/s1474-4422(23)00419-2.","journal-title":"Lancet Neurol"},{"key":"1012_CR5","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377:1723\u201332. https:\/\/doi.org\/10.1056\/NEJMoa1702752.","journal-title":"N Engl J Med"},{"key":"1012_CR6","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377:1713\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1706198.","journal-title":"N Engl J Med"},{"key":"1012_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S1474-4422(21)00367-7","volume":"21","author":"E Mercuri","year":"2022","unstructured":"Mercuri E, Deconinck N, Mazzone ES, Nascimento A, Oskoui M, Saito K, et al. Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2022;21:42\u201352. https:\/\/doi.org\/10.1016\/S1474-4422(21)00367-7.","journal-title":"Lancet Neurol"},{"key":"1012_CR8","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.nmd.2019.09.007","volume":"29","author":"DC De Vivo","year":"2019","unstructured":"De Vivo DC, Bertini E, Swoboda KJ, Hwu W-L, Crawford TO, Finkel RS, et al. Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: interim efficacy and safety results from the phase 2 NURTURE study. Neuromuscul Disord. 2019;29:842\u201356. https:\/\/doi.org\/10.1016\/j.nmd.2019.09.007.","journal-title":"Neuromuscul Disord"},{"key":"1012_CR9","unstructured":"Akron Children\u2019s Hospital. Adult or older patients policy. [Internet]. [cited 2026 Feb 20]. https:\/\/www.akronchildrens.org\/pages\/Adult-or-older-patients-policy.html. Accessed 20 Feb 2026."},{"key":"1012_CR10","unstructured":"Children\u2019s Hospital Colorado. Improving Pediatric to Adult Healthcare Transitions (ImPACT). [Internet]. [cited 2026 May 28]. https:\/\/www.childrenscolorado.org\/doctors-and-departments\/departments\/pediatric-transition-to-adult\/. Accessed 28 May 2026."},{"key":"1012_CR11","unstructured":"White P, Schmidt A, Shorr J, Ilango S, Beck D, McManus M. Six Core elements of health care transitionTM3.0 [Internet]. GotTransition.org. Washington, D.C; 2020 [cited 2025 Nov 5]. https:\/\/www.gottransition.org\/six-core-elements\/. Accessed 5 Nov 2025."},{"key":"1012_CR12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2587","volume":"142","author":"P White","year":"2018","unstructured":"White P, Cooley W, Transitions Clinical Report Authoring Group, American Academy of Pediatrics, American Academy of Family Physicians, American College of Physicians. Supporting the health care transition from adolescence to adulthood in the medical home. Pediatrics. 2018;142:e20182587. https:\/\/doi.org\/10.1542\/peds.2018-2587.","journal-title":"Pediatrics"},{"key":"1012_CR13","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1542\/peds.2012-3050","volume":"131","author":"MA McManus","year":"2013","unstructured":"McManus MA, Pollack LR, Cooley WC, McAllister JW, Lotstein D, Strickland B, et al. Current status of transition preparation among youth with special needs in the United States. Pediatrics. 2013;131:1090\u20137. https:\/\/doi.org\/10.1542\/peds.2012-3050.","journal-title":"Pediatrics"},{"key":"1012_CR14","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1007\/s10995-012-1192-7","volume":"17","author":"DP Oswald","year":"2013","unstructured":"Oswald DP, Gilles DL, Cannady MS, Wenzel DB, Willis JH, Bodurtha JN. Youth with special health care needs: transition to adult health care services. Matern Child Health J. 2013;17:1744\u201352. https:\/\/doi.org\/10.1007\/s10995-012-1192-7.","journal-title":"Matern Child Health J"},{"key":"1012_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1052-2","volume":"14","author":"HWY Wan","year":"2019","unstructured":"Wan HWY, Carey KA, D\u2019Silva A, Kasparian NA, Farrar MA. Getting ready for the adult world\u201d: how adults with spinal muscular atrophy perceive and experience healthcare, transition and well-being. Orphanet J Rare Dis. 2019;14:74. https:\/\/doi.org\/10.1186\/s13023-019-1052-2.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"1012_CR16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/22143602251377241","volume":"13","author":"J Munn","year":"2025","unstructured":"Munn J, Zaltz E, Izenberg A, Dale C, Ambreen M, Hammash N, et al. Understanding the experiences of adults with spinal muscular atrophy & their transition to an adult program: a mixed methods study. J Neuromuscul Dis. 2025;13(3):282\u201392. https:\/\/doi.org\/10.1177\/22143602251377241.","journal-title":"J Neuromuscul Dis."},{"key":"1012_CR17","unstructured":"State-of-SMA-Report2024_vWeb.pdf [Internet]. [cited 2026 Feb 20]. https:\/\/www.curesma.org\/wp-content\/uploads\/2025\/04\/State-of-SMA-Report2024_vWeb.pdf. Accessed 20 Feb 2026."},{"key":"1012_CR18","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-0194","volume":"142","author":"LA Lebrun-Harris","year":"2018","unstructured":"Lebrun-Harris LA, McManus MA, Ilango SM, Cyr M, McLellan SB, Mann MY, et al. Transition planning among US youth with and without special health care needs. Pediatrics. 2018;142:e20180194. https:\/\/doi.org\/10.1542\/peds.2018-0194.","journal-title":"Pediatrics"},{"key":"1012_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/pch\/pxac047","volume":"27","author":"A Toulany","year":"2022","unstructured":"Toulany A, Gorter JW, Harrison M. A call for action: recommendations to improve transition to adult care for youth with complex health care needs. Paediatr Child Health. 2022;27:297\u2013302. https:\/\/doi.org\/10.1093\/pch\/pxac047.","journal-title":"Paediatr Child Health"},{"key":"1012_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.pedn.2020.08.021","volume":"55","author":"M Varty","year":"2020","unstructured":"Varty M, Speller-Brown B, Phillips L, Kelly KP. Youths\u2019 experiences of transition from pediatric to adult care: an updated qualitative metasynthesis. J Pediatr Nurs. 2020;55:201\u201310. https:\/\/doi.org\/10.1016\/j.pedn.2020.08.021.","journal-title":"J Pediatr Nurs"},{"key":"1012_CR21","unstructured":"American College of Physicians. Pediatric to adult care transitions toolkit [Internet]. 2017 [cited 2026 Mar 12]. https:\/\/www.acponline.org\/clinical-information\/high-value-care\/resources-for-clinicians\/pediatric-to-adult-care-transitions-initiative\/condition-specific-tools. Accessed 12 Mar 2026."},{"key":"1012_CR22","unstructured":"Schmidt A, McManus M, White P, Muntean-Turner S, Lalor K. 2025 Coding and Payment Resource for Transition from Pediatric to Adult Health Care. Washington, DC: Got Transition, The National Alliance to Advance Adolescent Health; 2025. [cited 2026 May 28]. Available from: https:\/\/www.gottransition.org\/resource\/?2025-coding-tip-sheet. Accessed 28 May 2026."},{"key":"1012_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3233\/JND-200611","volume":"8","author":"MC Walter","year":"2021","unstructured":"Walter MC, Chiriboga C, Duong T, Goemans N, Mayhew A, Ouillade L, et al. Improving care and empowering adults living with SMA: a call to action in the new treatment era. J Neuromuscul Dis. 2021;8:543\u201351. https:\/\/doi.org\/10.3233\/JND-200611.","journal-title":"J Neuromuscul Dis"},{"key":"1012_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03973-0","volume":"20","author":"LL Tosi","year":"2025","unstructured":"Tosi LL, Hart TS, Beug G, Carter E, Perfetto EM. Somewhere to go: a position paper on addressing gaps in transition care for adults with childhood-onset rare diseases. Orphanet J Rare Dis. 2025;20:498. https:\/\/doi.org\/10.1186\/s13023-025-03973-0.","journal-title":"Orphanet J Rare Dis"},{"key":"1012_CR25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-066905","volume":"156","author":"SM Ilango","year":"2025","unstructured":"Ilango SM, Sappenfield OR, Lebrun-Harris LA, McManus MM, White PH, Ware A, et al. Disparities in health care transition preparation among US youth. Pediatrics. 2025;156:e2024066905. https:\/\/doi.org\/10.1542\/peds.2024-066905.","journal-title":"Pediatrics"},{"key":"1012_CR26","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-062275","volume":"153","author":"K Bailey","year":"2023","unstructured":"Bailey K, Avolio J, Lo L, Gajaria A, Mooney S, Greer K, et al. Social and structural drivers of health and transition to adult care. Pediatrics. 2023;153:e2023062275. https:\/\/doi.org\/10.1542\/peds.2023-062275.","journal-title":"Pediatrics"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-01012-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-026-01012-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-01012-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:03:04Z","timestamp":1790380984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-026-01012-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s40120-026-01012-z","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"23 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Lauren Eisenman, Angie Wise, and Mary Curry declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Recruitment materials, consent language, and survey content were reviewed and approved by the WCG Clinical Solutions Institutional Review Board on July 11, 2021 (IRB tracking number: 20213257). The IRB determined that the study met the criteria for a waiver of documentation of consent under 21 CFR 56.109(c). By proceeding with the survey, participants provided implied consent to participate.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}